Yahoo
OTC Markets OTCPK - Delayed Quote USD

Sonendo, Inc. (SONX)

1.2800 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for SONX
  • Previous Close 1.2800
  • Open 0.8500
  • Bid 0.3500 x 95000
  • Ask 1.8900 x 10200
  • Day's Range 0.8500 - 0.8500
  • 52 Week Range 0.0200 - 1.9000
  • Volume 999
  • Avg. Volume 213
  • Market Cap (intraday) 6.099M
  • Beta (5Y Monthly) 1.87
  • PE Ratio (TTM) --
  • EPS (TTM) -150.6800
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

sonendo.com

129

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SONX
326.67%
S&P 500 (^GSPC)
10.73%

1-Year Return

SONX
392.31%
S&P 500 (^GSPC)
11.11%

3-Year Return

SONX
97.51%
S&P 500 (^GSPC)
81.91%

5-Year Return

SONX
99.93%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY24
Revenue 8.3M
Earnings -6.37M
Profit Margin -76.71%

Q1

FY24

Q2

FY24

Q3

FY24

Q4

FY24

-5M
0
5M
-95.0%
-90.0%
-85.0%
-80.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -88.43%

  • Return on Assets (ttm)

    -33.32%

  • Return on Equity (ttm)

    -199.59%

  • Revenue (ttm)

    31.7M

  • Net Income Avi to Common (ttm)

    -33.54M

  • Diluted EPS (ttm)

    -150.6800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.63M

  • Total Debt/Equity (mrq)

    343.81%

  • Levered Free Cash Flow (ttm)

    -12.8M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: